FULLERTON, Calif., June 19 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. , a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming company presentations and investor events. Please mark your calendars accordingly.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) -- July 16 - 19, 2007, San Diego, California -- The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition. -- AACC will host its annual IVD Industry Analyst Briefing on Monday afternoon, July 16, 2007, from 1:30 p.m. to 5:30 p.m. at the Marriott Hotel and Marina. To RSVP, email: ftellez@aacc.org -- Beckman Coulter will host an investor event Tuesday, July 17, from 7:30 a.m. to 9:30 a.m. To receive full details, RSVP directly to Investor Relations at (714) 773-7620 or cgskoglund@beckman.com -- Industry Exhibits open on Tuesday, July 17 to 19, 2007, at 9:30 a.m. at the San Diego Convention Center, San Diego, California. For general meeting information, go to http://www.aacc.org. -- Q2 2007 Earnings Release scheduled for Wednesday, August 1, 2007. -- Beckman Coulter 2007 Annual Business Review. The executive management of the company will host one event in New York City, New York, on Tuesday, December 11, 2007: -- There will be a live webcast of this event. It will be accessible through Beckman Coulter’s website. Detailed dial in information to follow. -- The company will attend the following conferences: -- Thomas Weisel 2007 Healthcare Conference -- Wednesday, September 5, 2007, in Boston, Massachusetts. -- Bear Stearns 20th Annual Healthcare Conference -- Monday and Tuesday, September 10 and 11, 2007 in New York City, New York.
Please refer to the company’s website at http://www.beckmancoulter.com for updates on specific details of date and time for the company presentations referenced above. To access this information from our site, select “go to IR” under Investor Relations and look for “What’s Ahead”.
Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 75 percent of the company’s 2006 revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.
Contact: Cynthia Skoglund, (714) 773-8213, cgskoglund@beckman.com or Robert Raynor, (714) 773-7620, rraynor@beckman.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comBeckman Coulter, Inc.
CONTACT: Cynthia Skoglund, +1-714-773-8213, cgskoglund@beckman.com, orRobert Raynor, +1-714-773-7620, rraynor@beckman.com, both of BeckmanCoulter, Inc.
